Consistent with the involvement of TRA16-associated genes in the cell cycle, we observed an increased percentage of cells in the S or G2M phases among TRA16-positive cells across multiple cell types, including dendritic cells, fibroblasts, tumor-associated macrophages, and cancer cells (Figure 4E). This evidence concerns the gene NR2C2AP and cancer.